Pixels & Pills

Entries Tagged as 'audience'

3 Factors to Consider When Preparing to Shift Marketing Dollars Toward Social Media

May 20th, 2011 · No Comments · Uncategorized

By Michael Smith (@mikesmith55)
Capturing mindshare and market share is a key imperative for thriving organizations; social media is becoming an irresistible way of getting there. According to a report from research and consulting firm Borrell Associates, the amount U.S. companies spend marketing themselves on social networking sites like Facebook is expected to grow from an [...]

Share

[Read more →]

Tags:····················

GUEST BLOG POST: Dr. Google Is In

May 10th, 2011 · 4 Comments · Uncategorized

Today’s guest blog post is by Casey Williams, the Associate Director of Health Sciences at iProspect. Since joining the firm in 2006, Casey has focused on the health sciences market. She is responsible for strengthening relationships with iProspect’s clients in this field, and cultivating and disseminating health industry knowledge within iProspect and across its client [...]

Share

[Read more →]

Tags:······················

eHealthcare Solutions’ R.J. Lewis Shows Us the Benefits of Aggregating Niche Audiences

April 8th, 2011 · No Comments · Knowledge, News

R.J. Lewis, President & CEO of eHealthcare Solutions, discusses how his company’s approach benefits both publishers and marketers, and talks about how the healthcare advertising landscape has changed.

Share

[Read more →]

Tags:·············

Gerson Lehrman Group’s Jacquelyn Nicholson Helps Marketing & Brands Grow Their Strategies into New Media

January 19th, 2011 · No Comments · Knowledge, News

Jacquelyn Nicholson, Life Sciences Business Development at Gerson Lehrman Group, points out that there isn’t anything new in mobile technology and the discussion should be focused on understanding audience, consolidation, and insight.

Share

[Read more →]

Tags:··············

Advice You Never Get About Social Media

January 18th, 2011 · 2 Comments · Knowledge, Opinion

By Kimberly Reyes (@CommDuCoeur)
By now, you’ve heard it all: be authentic, identify the “super users,” don’t control the conversation, and so on and so forth. You’ve read all the blog posts written by some of the most influential social media experts (you’ve read enough to know that even social media experts hate the term “social [...]

Share

[Read more →]

Tags:················

Developing a Path to Digital Success

January 12th, 2011 · No Comments · Opinion

Today’s guest blog post is by Hans Wernke,Vice President, Digital Sales & Marketing, eMedFusion (a Division of KnowledgePoint360 Group). Hans is an experienced marketer and business development leader, with a strong focus on quality and innovation. After receiving his bachelor’s degree in education from Hogeschool Holland in Amsterdam, Hans worked for more than [...]

Share

[Read more →]

Tags:·······················

Future Vision

October 29th, 2010 · No Comments · Opinion

By Dan Bobear (@dbobear)
In many industries, economic conditions are slowly improving and as everybody becomes less stressed about job losses, furloughs and other ramifications of the recession, they’re ready to get back to business and get back to planning for the future.
For Pharma, that means being able to keep up with the quickly emerging and [...]

Share

[Read more →]

Tags:·····················

What Can You Do With 15 Seconds?

September 27th, 2010 · No Comments · Opinion

By Jason Brandt (@Jasondmg3)
In this recent Ad Age article, author and editor-at-large Jack Neff discusses new reseach showing that 30-second television commercials are declining in popularity in favor of half-sized 15-second increments. He goes on to specify that while there was a small increase in all national 15-second TV spots – so overall, short ads [...]

Share

[Read more →]

Tags:·············

AstraZeneca’s Brilinta

September 1st, 2010 · No Comments · News, Opinion

By Dan Bobear (@dbobear)
Now that AstraZeneca’s experimental blood thinner Brilinta has been given the green light by an advisory committee of the U.S. Food and Drug Administration, they need to prepare for the next hurdle they face: usurping category leader, Plavix, which is slated for generic availability sometime next year.
Most critical: changing physician prescribing behavior.
The [...]

Share

[Read more →]

Tags:·············

Clarity in Pharma Writing

August 27th, 2010 · No Comments · News, Opinion

By Kimberly Reyes (@CommDuCoeur)
Even if you are the most graphic of all designers, even if you are the most chemical of all researchers, you write at work.  You write reports, you write PowerPoint slides, you write emails, you write Post-It notes. You write staff reviews.  You write, and you tell the world about yourself every [...]

Share

[Read more →]

Tags:···········